These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 317467)

  • 21. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of contact activation of human plasma.
    Kaplan AP; Dunn JT; Silverberg M
    Adv Exp Med Biol; 1983; 156():45-61. PubMed ID: 6602463
    [No Abstract]   [Full Text] [Related]  

  • 23. Anaphylactic release of a prekallikrein activator from human lung in vitro.
    Meier HL; Kaplan AP; Lichtenstein LM; Revak S; Cochrane CG; Newball HH
    J Clin Invest; 1983 Aug; 72(2):574-81. PubMed ID: 6192147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prothrombin--substrate for blood plasma kallikrein and factor XIIa].
    Baskova IP; Tiero A; Krizhevskaia IuV; Iarovaia GA; Mirkamalova EG
    Biull Eksp Biol Med; 1983 Aug; 96(8):13-6. PubMed ID: 6603874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
    Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
    Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An international collaborative study to replace the 1st international standard for prekallikrein activator.
    Longstaff C; Behr-Gross ME; Daas A; Lackner F
    Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content.
    Römer J; Morgenthaler JJ; Scherz R; Skvaril F
    Vox Sang; 1982 Feb; 42(2):62-73. PubMed ID: 6977944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new prekallikrein activator in human plasma which differs from Hageman factor and its fragments.
    Webster ME; Stella RC; Villa ML; Toffoletto O
    Adv Exp Med Biol; 1979; 120B():53-9. PubMed ID: 517247
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.
    Tankersley DL; Alving BM; Finlayson JS
    Blood; 1983 Aug; 62(2):448-56. PubMed ID: 6191802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein.
    Egberg N; Overmark-Berggren I
    Thromb Res; 1983 Sep; 31(6):875-80. PubMed ID: 6557688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 37. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1985 Jul; 24(15):4124-30. PubMed ID: 3876845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An improved, reliable and practical kinetic assay for the detection of prekallikrein activator in blood products.
    Shin IS; Shim YB; Hong CM; Koh HC; Lee SH; Hong SH
    Arch Pharm Res; 2002 Aug; 25(4):505-10. PubMed ID: 12214864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of prekallikrein activator (PKA): the 1st International Standard for PKA.
    Kerry PJ; Curtis AD; Thomas DP
    Br J Haematol; 1985 Jun; 60(2):345-52. PubMed ID: 3873958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collaborative study to establish a new biological reference preparation for prekallikrein activator.
    Longstaff C; Behr-Gross ME; Daas A; Lackner F
    Pharmeuropa Bio; 2005 Sep; 2005(1):1-12. PubMed ID: 16336933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.